These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 29741774

  • 1. Management of post-transplant lymphoproliferative disorders.
    DeStefano CB, Desai SH, Shenoy AG, Catlett JP.
    Br J Haematol; 2018 Aug; 182(3):330-343. PubMed ID: 29741774
    [Abstract] [Full Text] [Related]

  • 2. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients.
    Preiksaitis JK.
    Clin Infect Dis; 2004 Oct 01; 39(7):1016-23. PubMed ID: 15472855
    [Abstract] [Full Text] [Related]

  • 3. Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.
    Marques HH, Shikanai-Yasuda MA, dAzevedo LS, Caiaffa-Filho HH, Pierrotti LC, Aquino MZ, Lopes MH, Maluf NZ, Campos SV, Costa SF.
    Rev Soc Bras Med Trop; 2014 Oct 01; 47(5):543-6. PubMed ID: 25467252
    [Abstract] [Full Text] [Related]

  • 4. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH, Russ GR, Coates PT.
    Nephrology (Carlton); 2006 Aug 01; 11(4):355-66. PubMed ID: 16889577
    [Abstract] [Full Text] [Related]

  • 5. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Aug 01; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 6. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov 01; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 7. Post-Transplantation Lymphoproliferative Disorders in Adults.
    Dierickx D, Habermann TM.
    N Engl J Med; 2018 Feb 08; 378(6):549-562. PubMed ID: 29414277
    [No Abstract] [Full Text] [Related]

  • 8. Management of post-transplant lymphoproliferative disorders.
    Llaurador G, McLaughlin L, Wistinghausen B.
    Curr Opin Pediatr; 2017 Feb 08; 29(1):34-40. PubMed ID: 27906865
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 08; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 10. Lymphoma: risk and response after solid organ transplant.
    Jacobson CA, LaCasce AS.
    Oncology (Williston Park); 2010 Sep 08; 24(10):936-44. PubMed ID: 21138175
    [Abstract] [Full Text] [Related]

  • 11. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH, Morrison VA.
    Expert Rev Hematol; 2010 Feb 08; 3(1):35-44. PubMed ID: 21082932
    [Abstract] [Full Text] [Related]

  • 12. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B.
    J Pediatr Hematol Oncol; 2014 Nov 08; 36(8):e481-6. PubMed ID: 24878618
    [Abstract] [Full Text] [Related]

  • 13. New approaches to posttransplant lymphoproliferative disorder (PTLD).
    Porcu P.
    Clin Adv Hematol Oncol; 2005 Jan 08; 3(1):24-6. PubMed ID: 16166963
    [No Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants.
    Stojanova J, Caillard S, Rousseau A, Marquet P.
    Pharmacol Res; 2011 Jan 08; 63(1):1-7. PubMed ID: 21056103
    [Abstract] [Full Text] [Related]

  • 15. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation.
    Green M.
    Am J Transplant; 2001 Jul 08; 1(2):103-8. PubMed ID: 12099356
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 08; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 17. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 08; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients.
    Wistinghausen B, Gross TG, Bollard C.
    Pediatr Hematol Oncol; 2013 Sep 08; 30(6):520-31. PubMed ID: 23802715
    [Abstract] [Full Text] [Related]

  • 19. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Kabasawa N, Shiozawa E, Murai S, Homma M, Uesugi Y, Matsui T, Nakata A, Shimada S, Sasaki Y, Baba Y, Watanuki M, Arai N, Fujiwara S, Kawaguchi Y, Tsukamoto H, Uto Y, Yanagisawa K, Hattori N, Sakai H, Harada H, Nakamaki T, Takimoto M, Yamochi-Onizuka T.
    J Clin Exp Hematop; 2021 Sep 08; 61(3):120-125. PubMed ID: 34511544
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 08; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.